市场调查报告书

传染病检查的全球市场:2025年为止的预测与市场机会

Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品编码 938724
出版日期 内容资讯 英文 112 Pages
商品交期: 请询问到货日
价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

传染病检查的全球市场:2025年为止的预测与市场机会 Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日内容资讯: 英文 112 Pages
简介

全球传染病检查市场在预测期间内预计将以惊人的年复合成长率成长。全球传染病检查市场成长的主要因素有全球感染疾病的人口增加。再加上全世界的政府对医疗基础设施的投资,预计将推动在预测期间内的市场成长。此外,医疗保健领域研发活动的增加预计将在未来几年进一步加强市场增长。

本报告提供各市场区隔和各地区的全球传染病检查市场调查,提供市场规模及市场占有率的预测,推动因素与课题,市场趋势,竞争情形,企业简介等资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 COVID-19对全球传染病检查市场的影响

第4章 摘要整理

第5章 客户的回响

第6章 全球传染病检查市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各产品及服务(化验,套件,及试剂,设备,服务及软体)
    • 各技术(免疫诊断,临床微生物学,聚合酵素链锁反应(PCR),恒温核酸增幅技术(INAAT),DNA序列&下一代序列(NGS),DNA微阵列,其他)
    • 各疾病(肝炎,HIV,HAIS,HPV,TB,流感,腺性热,冠状病毒,其他)
    • 各终端用户(医院/临床检验室,参照检验室,医生的办公室,学术/ 调查机关,其他)
    • 各公司
    • 各地区
  • 市场魅力指数

第7章 亚太地区的传染病检查市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各产品及服务
    • 各技术
    • 各疾病
    • 各终端用户
    • 各国
    • 竞争的展望
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国
    • 印尼
    • 新加坡
    • 马来西亚

第8章 欧洲的传染病检查市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各产品及服务
    • 各技术
    • 各疾病
    • 各终端用户
    • 各国
    • 竞争的展望
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 土耳其

第9章 北美的传染病检查市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各产品及服务
    • 各技术
    • 各疾病
    • 各终端用户
    • 各国
    • 竞争的展望
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第10章 南美的传染病检查市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各产品及服务
    • 各技术
    • 各疾病
    • 各终端用户
    • 各国
    • 竞争的展望
  • 南美:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 中东·非洲的传染病检查市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各产品及服务
    • 各技术
    • 各疾病
    • 各终端用户
    • 各国
    • 竞争的展望
  • 中东·非洲:国家分析
    • 南非
    • 沙乌地阿拉伯
    • UAE
    • 埃及
    • 奈及利亚

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势与发展

第14章 专利分析

第15章 竞争情形

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Luminex
  • Meridian Bioscience
  • Quidel
  • Roche Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific
  • Johnson and Johnson
  • F. Hoffmann-La Roche Ltd
  • Cepheid

第16章 策略性推荐事项

第17章 免责声明

目录
Product Code: 4695

Global infectious disease testing market is expected to grow at a significant CAGR during the forecast period. The global infectious disease testing market is driven by rising populace having infectious diseases across the globe. Moreover, investments in healthcare infrastructure by governments across the globe is expected to fuel the growth of market during the forecast period. Also, increase in research and developmental activities in the healthcare sector is further expected to bolster the growth of market over the next few years.

The global infectious disease testing market is segmented based on product and service, technology, disease, end user, company, and region. Based on product and service, the market can be categorized into assays, kits, & reagents; instruments; services & software. Out of which, the assays, kits, & reagents segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to ease of accessibility coupled with rising number of IDD tests that are being conducted. In addition to this, the volume of IDD tests is growing primarily because of increasing geriatric population along with rising incidence of infectious diseases. Moreover, ongoing development of newer, faster, and more reliable products is further anticipated to boost the growth of segment over the coming years. Along with that, the reagents are available in variety, which is further aiding the market growth.

Major players operating in the global infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann-La Roche Ltd, Cepheid, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global infectious disease testing market from 2015 to 2018.
  • To estimate and forecast the market size of global infectious disease testing market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global infectious disease testing market based on product and service, technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global infectious disease testing market.
  • To identify drivers and challenges for global infectious disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global infectious disease testing market.
  • To conduct pricing analysis for global infectious disease testing market.
  • To identify and analyze the profile of leading players operating in global infectious disease testing market.
  • To identify key sustainable strategies adopted by market players in global infectious disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global infectious disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Infectious disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to infectious disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global infectious disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Infectious Disease Testing Market, By Product and Service:

Assays, Kits, & Reagents

Instruments

Services & Software

  • Global Infectious Disease Testing Market, By Technology:

Immunodiagnostics

Clinical Microbiology

Polymerase Chain Reaction

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-Generation Sequencing

DNA Microarray

Other Technologies

  • Global Infectious Disease Testing Market, By Disease:

Hepatitis

HIV

HAIS

HPV

TB

Influenza

Glandular fever

Coronavirus

Others

  • Global Infectious Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Reference Laboratories

Physician Offices

Academic/Research Institutes

Other

  • Global Infectious Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Netherland
  • Russia
  • Turkey

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Malaysia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global infectious disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Infectious Disease Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Infectious Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software)
    • 6.2.2. By Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)
    • 6.2.3. By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular fever, Coronavirus, Others)
    • 6.2.4. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Infectious Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Technology
    • 7.2.3. By Disease
    • 7.2.4. By End User
    • 7.2.5. By Country
    • 7.2.6. Competition Outlook
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Infectious Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. India Infectious Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Infectious Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Infectious Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Disease
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Infectious Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Disease
        • 7.3.5.2.4. By End User
    • 7.3.6. Indonesia Infectious Disease Testing Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product and Service
        • 7.3.6.2.2. By Technology
        • 7.3.6.2.3. By Disease
        • 7.3.6.2.4. By End User
    • 7.3.7. Singapore Infectious Disease Testing Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Product and Service
        • 7.3.7.2.2. By Technology
        • 7.3.7.2.3. By Disease
        • 7.3.7.2.4. By End User
    • 7.3.8. Malaysia Infectious Disease Testing Market Outlook
      • 7.3.8.1. Market Size & Forecast
        • 7.3.8.1.1. By Value
      • 7.3.8.2. Market Share & Forecast
        • 7.3.8.2.1. By Product and Service
        • 7.3.8.2.2. By Technology
        • 7.3.8.2.3. By Disease
        • 7.3.8.2.4. By End User

8. Europe Infectious Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Technology
    • 8.2.3. By Disease
    • 8.2.4. By End User
    • 8.2.5. By Country
    • 8.2.6. Competition Outlook
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Infectious Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Infectious Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Infectious Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Infectious Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Infectious Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User
    • 8.3.6. Netherland Infectious Disease Testing Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Product and Service
        • 8.3.6.2.2. By Technology
        • 8.3.6.2.3. By Disease
        • 8.3.6.2.4. By End User
    • 8.3.7. Russia Infectious Disease Testing Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Product and Service
        • 8.3.7.2.2. By Technology
        • 8.3.7.2.3. By Disease
        • 8.3.7.2.4. By End User
    • 8.3.8. Turkey Infectious Disease Testing Market Outlook
      • 8.3.8.1. Market Size & Forecast
        • 8.3.8.1.1. By Value
      • 8.3.8.2. Market Share & Forecast
        • 8.3.8.2.1. By Product and Service
        • 8.3.8.2.2. By Technology
        • 8.3.8.2.3. By Disease
        • 8.3.8.2.4. By End User

9. North America Infectious Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Technology
    • 9.2.3. By Disease
    • 9.2.4. By End User
    • 9.2.5. By Country
    • 9.2.6. Competition Outlook
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Infectious Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Infectious Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Infectious Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User

10. South America Infectious Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Technology
    • 10.2.3. By Disease
    • 10.2.4. By End User
    • 10.2.5. By Country
    • 10.2.6. Competition Outlook
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Infectious Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Infectious Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Infectious Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Infectious Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Technology
    • 11.2.3. By Disease
    • 11.2.4. By End User
    • 11.2.5. By Country
    • 11.2.6. Competition Outlook
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Infectious Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Infectious Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Infectious Disease Testing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product and Service
        • 11.3.4.2.2. By Technology
        • 11.3.4.2.3. By Disease
        • 11.3.4.2.4. By End User
    • 11.3.5. Nigeria Infectious Disease Testing Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product and Service
        • 11.3.5.2.2. By Technology
        • 11.3.5.2.3. By Disease
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Abbott Laboratories
  • 15.2. Becton, Dickinson and Company
  • 15.3. Biomerieux SA
  • 15.4. Bio-Rad Laboratories
  • 15.5. Danaher Corporation
  • 15.6. Diasorin
  • 15.7. Luminex
  • 15.8. Meridian Bioscience
  • 15.9. Quidel
  • 15.10. Roche Diagnostics
  • 15.11. Siemens AG
  • 15.12. Thermo Fisher Scientific
  • 15.13. Johnson and Johnson
  • 15.14. F. Hoffmann-La Roche Ltd
  • 15.15. Cepheid

16. Strategic Recommendations

17. About Us & Disclaimer